ConductScience.org, home

Paper41547728

Prognostic significance of neuroendocrine differentiation and PD-L1 expression in treatment-naïve prostate cancer.

Tosun I and 4 others. BMC Urol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Prognostic significance of neuroendocrine differentiation and PD-L1 expression in treatment-naïve prostate cancer. Papers, record 41547728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41547728

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic significance of neuroendocrine differentiation and PD-L1 expression in treatment-naïve prostate cancer.
PubMed
Journal
BMC Urol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-06-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tosun IIlkay
2Sahin OOnur
3Bakkaloğlu İGİrem Güvendir
4Şişik NMNurullah Mustafa
5Özçelik MMelike

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
B7-H1 AntigenMajor topic
AdenocarcinomaMajor topic
Humans
Male
Prognosis
Retrospective Studies
Aged
Synaptophysin
Middle Aged
Cell Differentiation

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124705311Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.Am J Surg Pathol2014https://conductscience.org/library/papers/24705311PubMed
233339136Neuroendocrine and Aggressive-Variant Prostate Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/33339136PubMed
329985747Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.J Clin Oncol2018https://conductscience.org/library/papers/29985747PubMed
438808339Treatment-induced neuroendocrine prostate cancer and de novo neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors.World J Clin Cases2024https://conductscience.org/library/papers/38808339PubMed
525606573Neuroendocrine differentiation of prostate cancer: a review.Am J Clin Exp Urol2014https://conductscience.org/library/papers/25606573PubMed
628893901Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide.Clin Cancer Res2017https://conductscience.org/library/papers/28893901PubMed
734784097Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis.BJU Int2022https://conductscience.org/library/papers/34784097PubMed
839380471The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.Oncology2025https://conductscience.org/library/papers/39380471PubMed
929535806Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer.Oncotarget2018https://conductscience.org/library/papers/29535806PubMed
1038423221Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.Hum Pathol2024https://conductscience.org/library/papers/38423221PubMed
1140273724PD - L1 (SP263) expression correlates with pathological aggressive parameters in prostate cancer.Ann Diagn Pathol2025https://conductscience.org/library/papers/40273724PubMed
1239279246Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53.Prostate2024https://conductscience.org/library/papers/39279246PubMed
1329297494Neuroendocrine tumors of the prostate.Mod Pathol2018https://conductscience.org/library/papers/29297494PubMed
1428788048Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.Int J Mol Sci2017https://conductscience.org/library/papers/28788048PubMed
1532474391Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.Crit Rev Oncol Hematol2020https://conductscience.org/library/papers/32474391PubMed
1632344931Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer.Cells2020https://conductscience.org/library/papers/32344931PubMed
1731547070Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play.Cancers (Basel)2019https://conductscience.org/library/papers/31547070PubMed
1831061129Genomic correlates of clinical outcome in advanced prostate cancer.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31061129PubMed
1922767265Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer.Virchows Arch2012https://conductscience.org/library/papers/22767265PubMed
2038173302Diagnosis and management of neuroendocrine prostate cancer.Prostate2024https://conductscience.org/library/papers/38173302PubMed

See all 25 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
SYP6855PubTator's text mininghttps://conductscience.org/library/genes/6855NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41547728

GET https://conductscience.org/api/papers/v1/41547728/references?page=2